SAB Biotherapeutics, Inc. (SABSW) Earning

$0.09

south_east -$0.01 (-10%)
Day's range
$0.09
Day's range
$0.09
Actual EPS
SABSW Earnings Estimates and Actuals by Quarter$2$2$0$0-$2-$2-$4-$4-$6-$6Q4 2024Q4 2024Q1 2021Q1 2021Q3 2021Q3 2021Q1 2022Q1 2022Q3 2022Q3 2022Q1 2023Q1 2023Q3 2023Q3 2023Q1 2024Q1 2024
Download SVG
Download PNG
Download CSV

SAB Biotherapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 0 $0.00 $0.00 $0.00
Q1 2025 0 $0.00 $0.00 $0.00

SAB Biotherapeutics, Inc. Earnings Date And Information

SAB Biotherapeutics, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 2.24 M for the year. SAB Biotherapeutics, Inc. has generated $-8 earnings per share over the last year ($-7.64 diluted earnings per share) and currently has a price-to-earnings ratio of -0.85. SAB Biotherapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based on prior year's report dates.

SAB Biotherapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/06/2024 Q3 2024 -$1.12 $0
08/08/2024 Q2 2024 -$0.79 $263,137
05/20/2024 Q1 2024 -$0.54 $944,575
03/28/2024 Q4 2023 -$3.86 $305,011
11/13/2023 Q3 2023 -$0.97 $1.27 M
08/21/2023 Q2 2023 -$1.36 $85,518
05/15/2023 Q1 2023 -$1.47 $581,101
04/28/2023 Q4 2022 -$1.56 $2.16 M
11/14/2022 Q3 2022 -$1.47 $3.59 M
08/09/2022 Q2 2022 -$1.11 $6.35 M
05/12/2022 Q1 2022 $0.23 $11.80 M
04/28/2023 Q4 2021 -$4.11 $60.88 M
11/22/2021 Q3 2021 -$0.08 $0
08/09/2021 Q2 2021 -$0.68 $0
05/21/2021 Q1 2021 $0.32 $0
04/02/2021 Q4 2020 -$0.01 $0
 

SAB Biotherapeutics, Inc. Earnings: FAQ's

When is SAB Biotherapeutics, Inc.'s earnings date?

SAB Biotherapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.

How can I listen to SAB Biotherapeutics, Inc.'s earnings conference call?

The conference call for SAB Biotherapeutics, Inc.'s latest earnings report can be listened to online.

How can I read SAB Biotherapeutics, Inc.'s conference call transcript?

The conference call transcript for SAB Biotherapeutics, Inc.'s latest earnings report can be read online.

How much revenue does SAB Biotherapeutics, Inc. generate each year?

SAB Biotherapeutics, Inc. (:SABSW) has a recorded annual revenue of $2.24 M.

How much profit does SAB Biotherapeutics, Inc. generate each year?

SAB Biotherapeutics, Inc. (:SABSW) has a recorded net income of $2.24 M. SAB Biotherapeutics, Inc. has generated $-7.64 earnings per share over the last four quarters.

What is SAB Biotherapeutics, Inc.'s price-to-earnings ratio?

SAB Biotherapeutics, Inc. (:SABSW) has a price-to-earnings ratio of -0.85 and price/earnings-to-growth ratio is 0.35.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED